Mone Zaidi

Mone Zaidi is an endowed Mount Sinai Professor of Clinical Medicine and Director of the Center for Translational Medicine at the Icahn School of Medicine at Mount Sinai, New York. With a career spanning over three decades, he has held leadership roles such as Chief of Endocrinology and Associate Dean at multiple institutions, including the Medical College of Pennsylvania and Veterans Affairs Hospitals in New York and Philadelphia.

• Education: MD and PhD from the University of London (Hammersmith Hospital).

His research focuses on endocrine regulation of skeletal homeostasis, pituitary-bone axis, and FSH inhibition as a therapeutic target for osteoporosis, obesity, and neurodegeneration. His groundbreaking work on FSH blocking antibodies and hormonal crosstalk between bone, fat, and brain has been recognized in Nature, Cell, and PNAS, with over 450 publications and continuous funding from the NIH and UK’s MRC.

Recent articles highlight therapeutic strategies for osteoporosis, neurodegenerative diseases, and metabolic disorders through hormonal modulation. His work has been featured in Nature Medicine, New York Times, and Newsweek, including selection as one of the 8 'Notable Advances' in biomedicine for 2017.

Scientific Awards

• Doctor of Science Honoris Causa (University of Connecticut, King Georges Medical College, Sanjay Gandhi Postgraduate Institute, Amity University, University of Bari)
• Master of the American College of Physicians (2017)
• Elected Fellow of the U.S. National Academy of Inventors (2022), AAAS (2019), and Royal Society of Biology (1996)
• Austrian International Research Prize (2022)
• Harrington Scholar–Innovator Award (2017)